TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bio-Nord AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,481
|
1,273
|
1,092 |
Financial expenses |
104
|
26
|
1 |
Earnings before taxes |
89
|
7
|
-38 |
EBITDA |
193
|
33
|
-37 |
Total assets |
983
|
1,976
|
1,197 |
Current assets |
983
|
1,976
|
1,197 |
Current liabilities |
846
|
1,884
|
1,119 |
Equity capital |
109
|
64
|
58 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
11.1%
|
3.2%
|
4.8% |
Turnover per employee |
494
|
424
|
364 |
Profit as a percentage of turnover |
6.0%
|
0.5%
|
-3.5% |
Return on assets (ROA) |
19.6%
|
1.7%
|
-3.1% |
Current ratio |
116.2%
|
104.9%
|
107.0% |
Return on equity (ROE) |
81.7%
|
10.9%
|
-65.5% |
Change turnover |
208
|
181
|
-613 |
Change turnover % |
16%
|
17%
|
-36% |
Chg. No. of employees |
0
![]() |
0
|
-1 |
Chg. No. of employees % |
0%
![]() |
0%
|
-25% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.